G.S. Avery
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
- Inflammatory mediators and NSAID effects
- Pharmaceutical Science top 0.5%
Papers in
- Pharmacology 41
- Inflammatory mediators and NSAID effects 17
- Antibiotics Pharmacokinetics and Efficacy 16
- Treatment of Major Depression 7
-
- Blood Pressure and Hypertension Studies 14
- Co-authors
- T.M. Speight (128 shared papers)Rex N. Brogden (129 shared papers)Rennie C. Heel (81 shared papers)R. M. Pinder (19 shared papers)Andrea Carmine (13 shared papers)Phyllis R. Sawyer (16 shared papers)Gary E. Pakes (10 shared papers)B. Holmes (3 shared papers)
- Journals
- Drugs (134 papers)Virtual Defense Library (Ministerio de Defensa) (1 paper)Medical Entomology and Zoology (2 papers)Springer eBooks (3 papers)
In The Last Decade
G.S. Avery
139 papers receiving 9.6k citations
G.S. Avery's Hit Papers
Peers
Comparison fields: 5 of 152
- Pharmacology 1.5k
- Pharmacology 821
- Pharmaceutical Science 532
- Gastroenterology 439
- Toxicology 330
Countries citing papers authored by G.S. Avery
This map shows the geographic impact of G.S. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.S. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.S. Avery more than expected).
Fields of papers citing papers by G.S. Avery
This network shows the impact of papers produced by G.S. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.S. Avery. The network helps show where G.S. Avery may publish in the future.
Co-authors
The 16 scholars most cited alongside G.S. Avery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Buprenorphine Hit paper breakdown → | 1979 | 319 |
| 2 | 1982 | 304 | |
| 3 | 1977 | 281 | |
| 4 | 1979 | 278 | |
| 5 | 1976 | 273 | |
| 6 | 1980 | 271 | |
| 7 | 1978 | 260 | |
| 8 | 1982 | 247 | |
| 9 | 1982 | 244 | |
| 10 | 1984 | 236 | |
| 11 | 1980 | 218 | |
| 12 | 1984 | 197 | |
| 13 | 1975 | 189 | |
| 14 | 1982 | 183 | |
| 15 | 1984 | 175 | |
| 16 | 1976 | 170 | |
| 17 | 1976 | 169 | |
| 18 | 1981 | 164 | |
| 19 | 1977 | 163 | |
| 20 | 1977 | 160 |
About G.S. Avery
G.S. Avery is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Gastroenterology, Anesthesiology and Pain Medicine and Dermatology, having authored 142 papers that have together received 11.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Blood Pressure and Hypertension Studies (14 papers), Asthma and respiratory diseases (9 papers), Treatment of Major Depression (7 papers), Gastrointestinal Bleeding Diagnosis and Treatment (5 papers), Antifungal resistance and susceptibility (5 papers) and Pain Management and Opioid Use (5 papers). The work is most often cited by research in Pharmacology (1.5k citations), Pharmacology (821 citations), Pharmaceutical Science (532 citations), Gastroenterology (439 citations) and Toxicology (330 citations). Frequent co-authors include T.M. Speight, Rex N. Brogden, Rennie C. Heel, R. M. Pinder, Andrea Carmine, Phyllis R. Sawyer, Gary E. Pakes, B. Holmes, Alan Ward and John A. Romankiewicz. Their work appears in journals such as Drugs, Virtual Defense Library (Ministerio de Defensa), Medical Entomology and Zoology and Springer eBooks.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.